This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Reckitt Benckiser Enfamil Class Action
Business class action lawsuit

Reckitt Benckiser Enfamil Class Action

Analysis based on 50 articles · First reported Jun 07, 2025 · Last updated Aug 04, 2025

Sentiment
-50
Attention
4
Articles
50
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against Reckitt for alleged securities fraud regarding its Enfamil formula could lead to significant financial liabilities and a decline in its stock price. This event highlights the importance of corporate transparency and product safety in the pharmaceutical and consumer goods industries, potentially impacting investor confidence in similar companies.

pharmaceuticals legal services
Event Summary

Reckitt Group plc is facing multiple class action lawsuits from law firms including Rosen Law Firm, Levi & Korsinsky, and The Gross Law Firm. The lawsuits allege that Reckitt made false and misleading statements by concealing the increased risk of necrotizing enterocolitis (NEC) in preterm infants consuming its cow's milk-based formula, Enfamil. The class period for the alleged securities fraud is between January 13, 2021, and July 28, 2024. Investors who suffered losses during this period are being encouraged to join the lawsuit, with an important lead plaintiff deadline of August 4, 2025. The legal actions highlight potential significant financial and reputational damage for Reckitt due to product liability and securities law violations.

Key Actions
100 Rosen Law Firm filed class action lawsuit Reckitt
95 Reckitt issued false statements
90 Levi & Korsinsky filed class action lawsuit Reckitt
Entities Involved
stock
Reckitt
Reckitt is facing a class action lawsuit for allegedly concealing the increased risk of NEC in preterm infants consuming its cow's milk-based formula, Enfamil, which could lead to significant financial losses and reputational damage.
Importance 100.0 Sentiment -70.0
priv
Enfamil
Enfamil, a cow's milk-based formula produced by Reckitt, is at the center of the class action lawsuit due to allegations that it increases the risk of NEC in preterm infants, impacting its sales and exposing Reckitt to legal claims.
Importance 70.0 Sentiment -50.0
per
Lawrence Rosen
Lawrence Rosen, founding partner of Rosen Law Firm, is involved in the firm's efforts to represent investors in the class action against Reckitt.
Importance 70.0 Sentiment 50.0
per
Philip Kim
Philip Kim, an attorney at Rosen Law Firm, is a key contact for investors interested in joining the class action lawsuit against Reckitt.
Importance 70.0 Sentiment 50.0
per
Joseph E. Levi
Importance 0.0 Sentiment 0.0
priv
Levi & Korsinsky
Importance 0.0 Sentiment 0.0
priv
Rosen Law Firm
Importance 0.0 Sentiment 0.0
Relationships
Lawrence Rosen founding partner ↔ Philip Kim Lawrence Rosen is a founding partner of the Rosen Law Firm, where he directs attorneys including Philip Kim. Together, t
Lawrence Rosen related ↔ Joseph E. Levi
Lawrence Rosen related ↔ Levi & Korsinsky
Lawrence Rosen founding partner ↔ Rosen Law Firm Lawrence Rosen is a founding partner of the Rosen Law Firm, a prominent legal practice specializing in securities class
Philip Kim related ↔ Joseph E. Levi
Philip Kim related ↔ Levi & Korsinsky
Philip Kim attorney ↔ Rosen Law Firm Philip Kim is an attorney at Rosen Law Firm, where he acts as a key contact and represents investors in various securiti
Joseph E. Levi partner ↔ Levi & Korsinsky Joseph E. Levi is an attorney and named partner at Levi & Korsinsky, where he represents investors in securities class a
Joseph E. Levi related ↔ Rosen Law Firm
Levi & Korsinsky related ↔ Rosen Law Firm
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.